Market Cap 3.37M
Revenue (ttm) 5.03M
Net Income (ttm) -7.88M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 22,600
Avg Vol 21,120
Day's Range N/A - N/A
Shares Out 4.41M
Stochastic %K 50%
Beta 1.12
Analysts Strong Buy
Price Target $2.50

Company Profile

Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through EasyDNA, AffinityDNA, and GeneType/Corporate segments. It offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. The company also markets BREVAGenp...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 61 3 8412 7000
Fax: 61 3 8412 7040
Address:
321 Chapel Street, Level 1 Suite 7, Prahran, Australia
DrevanTheStillblade
DrevanTheStillblade Oct. 17 at 9:23 PM
The next 10x play? VRME !!!! That gives upside room without intense short squeeze pressure. If technicals break, this could pick up momentum fast. $STRR $PTPI $GENE $BTTX
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 17 at 7:58 AM
VRME The valuation disconnect is glaring: $VRME’s P/Cash Flow is 15× while many peers trade at much higher multiples.  With a golden cross forming and macro rotation into tech/AI, this could be one of the stealth names to watch….. $FTSV $GLMD $ZIVO $GENE
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 17 at 7:38 AM
VRME has real business brand protection + precision logistics not just hype.  It’s currently underpriced vs its peers. If the chart confirms a golden cross while building strength above $1.00, we could see serious upside. $ACXP $GENE $BTTX $QH
0 · Reply
Popeye989
Popeye989 Oct. 14 at 3:17 PM
$GENE once upon a time you made me a lot of money. Now we part ways
0 · Reply
MilsLearning
MilsLearning Oct. 10 at 5:19 PM
$GENE Ever get bullied??? Trading stocks?? Me too!!! Well 🖕🩳🖕🔥🔥🔥🩳🖕🩳🔥
0 · Reply
TradeHuntFish
TradeHuntFish Oct. 7 at 11:13 AM
watch PRHI Traders always look after the run. s giving every early signal now. 98 short squeeze score, micro float, no borrow, golden cross forming. And nobody’s loading? This is the type of setup that makes careers... $GENE $BTTX $MBRX $XELA $SERA
0 · Reply
TradeHuntFish
TradeHuntFish Oct. 3 at 1:06 PM
GIPR is the kind of play that only makes sense before it takes off. Real estate backed. Undervalued. And now with serious whispers of a crypto treasury strategy that could turn this into the next multi-sector rocket. 20x–50x isn’t hype it’s math if they execute. $ZVSA $IMUX $GENE $BTTX $ACXP
0 · Reply
LoveNvidia
LoveNvidia Oct. 3 at 2:37 AM
Looks like volume & momentum could be shifting in to ASTC! Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $FEMY $FLJ $GENE $GETR tomorrow
2 · Reply
VincentVanGoghh
VincentVanGoghh Sep. 19 at 4:04 AM
VRME has everything lining up: ✔️ Cash flow positive ✔️ Golden cross forming ✔️ UPS deal in place ✔️ Tight float The chart is setting up for a textbook breakout and nobody’s paying attention yet. $ZVSA $NBY $AKAN $PALI $GENE
0 · Reply
CornPops_CornHole
CornPops_CornHole Aug. 21 at 9:43 PM
$GENE I used to dream of GENE, but it was all a pipe.....
0 · Reply
Latest News on GENE
Appendix 4C & Quarterly Business Update – March 2024

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Appendix 4C & Quarterly Business Update – March 2024


GTG to launch U.S. Customer Digital Media Sales Campaign

Feb 28, 2024, 8:00 AM EST - 1 year ago

GTG to launch U.S. Customer Digital Media Sales Campaign


Annual Results – Momentum Building on our Commercial Plans

Aug 30, 2023, 8:45 AM EDT - 2 years ago

Annual Results – Momentum Building on our Commercial Plans


New Publication Validates geneType for Melanoma Risk Assessment

Apr 28, 2023, 8:00 AM EDT - 2 years ago

New Publication Validates geneType for Melanoma Risk Assessment


Back-to-back Studies Validate geneType Breast Cancer Risk Test

Mar 13, 2023, 8:00 AM EDT - 2 years ago

Back-to-back Studies Validate geneType Breast Cancer Risk Test


GENE Momentum building - a year in review

Aug 30, 2022, 8:00 AM EDT - 3 years ago

GENE Momentum building - a year in review


Gene achieves key milestones and growth

Jul 28, 2022, 8:00 AM EDT - 3 years ago

Gene achieves key milestones and growth


GeneType Risk Assessment Test onboarding in 16 clinics

Jul 1, 2022, 8:00 AM EDT - 3 years ago

GeneType Risk Assessment Test onboarding in 16 clinics


Acquisition of global direct to consumer ecommerce business

May 16, 2022, 9:00 AM EDT - 3 years ago

Acquisition of global direct to consumer ecommerce business


DrevanTheStillblade
DrevanTheStillblade Oct. 17 at 9:23 PM
The next 10x play? VRME !!!! That gives upside room without intense short squeeze pressure. If technicals break, this could pick up momentum fast. $STRR $PTPI $GENE $BTTX
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 17 at 7:58 AM
VRME The valuation disconnect is glaring: $VRME’s P/Cash Flow is 15× while many peers trade at much higher multiples.  With a golden cross forming and macro rotation into tech/AI, this could be one of the stealth names to watch….. $FTSV $GLMD $ZIVO $GENE
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 17 at 7:38 AM
VRME has real business brand protection + precision logistics not just hype.  It’s currently underpriced vs its peers. If the chart confirms a golden cross while building strength above $1.00, we could see serious upside. $ACXP $GENE $BTTX $QH
0 · Reply
Popeye989
Popeye989 Oct. 14 at 3:17 PM
$GENE once upon a time you made me a lot of money. Now we part ways
0 · Reply
MilsLearning
MilsLearning Oct. 10 at 5:19 PM
$GENE Ever get bullied??? Trading stocks?? Me too!!! Well 🖕🩳🖕🔥🔥🔥🩳🖕🩳🔥
0 · Reply
TradeHuntFish
TradeHuntFish Oct. 7 at 11:13 AM
watch PRHI Traders always look after the run. s giving every early signal now. 98 short squeeze score, micro float, no borrow, golden cross forming. And nobody’s loading? This is the type of setup that makes careers... $GENE $BTTX $MBRX $XELA $SERA
0 · Reply
TradeHuntFish
TradeHuntFish Oct. 3 at 1:06 PM
GIPR is the kind of play that only makes sense before it takes off. Real estate backed. Undervalued. And now with serious whispers of a crypto treasury strategy that could turn this into the next multi-sector rocket. 20x–50x isn’t hype it’s math if they execute. $ZVSA $IMUX $GENE $BTTX $ACXP
0 · Reply
LoveNvidia
LoveNvidia Oct. 3 at 2:37 AM
Looks like volume & momentum could be shifting in to ASTC! Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $FEMY $FLJ $GENE $GETR tomorrow
2 · Reply
VincentVanGoghh
VincentVanGoghh Sep. 19 at 4:04 AM
VRME has everything lining up: ✔️ Cash flow positive ✔️ Golden cross forming ✔️ UPS deal in place ✔️ Tight float The chart is setting up for a textbook breakout and nobody’s paying attention yet. $ZVSA $NBY $AKAN $PALI $GENE
0 · Reply
CornPops_CornHole
CornPops_CornHole Aug. 21 at 9:43 PM
$GENE I used to dream of GENE, but it was all a pipe.....
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Aug. 4 at 3:57 PM
IBG🚨 This is one of the cleanest SPAC setups in the market right now. Micro float. No dilution. Merger potential on deck. It’s quiet now but when it moves, it’ll be too late to catch the bottom. Don’t blink. $DSS $CRKN $GENE $AVTX
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Aug. 4 at 2:26 AM
IBG A sleeper with no dilution, no baggage, and full breakout potential. This is where smart money hunts before the crowd. $HOOK $EVAX $GENE $PHGE
1 · Reply
Metal_Health
Metal_Health Jul. 31 at 10:30 PM
$IXHL semi-good news for stateside baggies soon they'll only dilute Australians like $GENE
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 2 at 10:38 AM
$SLS that uptick volume was me just now left something with your signature for markets its an old $GENE movement
2 · Reply
StocktwitsNews
StocktwitsNews May. 29 at 3:15 PM
The New York Times and Amazon Strike AI Content Deal: Retail’s Yet To React $NYT $AMZN $GENE $RSPC https://stocktwits.com/news/equity/markets/new-york-times-and-amazon-strike-ai-content-deal/ch0AswDRbtM
0 · Reply
IffiTrades
IffiTrades Apr. 30 at 4:02 PM
$GENE i remember making $16K on this stock in one day - RIP
0 · Reply
Brence04
Brence04 Mar. 21 at 5:18 PM
$GENE class action lawsuit here
1 · Reply
JAMESX5
JAMESX5 Mar. 20 at 2:35 PM
$GENE RIP
0 · Reply
CurtTyp3
CurtTyp3 Mar. 17 at 10:34 AM
0 · Reply
Vrod10
Vrod10 Mar. 5 at 9:22 PM
$GENE is there any news on this one since delisting?
1 · Reply
lax346
lax346 Feb. 10 at 9:21 PM
$GENE what happens with it? Is it closed or banrupt?
0 · Reply